BRPI0601834A - suplementação dietética para curar ou regredir sintomas de refluxo gastroesofágico, gastrite e úlceras - Google Patents
suplementação dietética para curar ou regredir sintomas de refluxo gastroesofágico, gastrite e úlcerasInfo
- Publication number
- BRPI0601834A BRPI0601834A BRPI0601834-3A BRPI0601834A BRPI0601834A BR PI0601834 A BRPI0601834 A BR PI0601834A BR PI0601834 A BRPI0601834 A BR PI0601834A BR PI0601834 A BRPI0601834 A BR PI0601834A
- Authority
- BR
- Brazil
- Prior art keywords
- ulcers
- cure
- gastritis
- symptoms
- gastroesophageal reflux
- Prior art date
Links
- 208000025865 Ulcer Diseases 0.000 title abstract 4
- 231100000397 ulcer Toxicity 0.000 title abstract 4
- 208000007882 Gastritis Diseases 0.000 title abstract 2
- 235000015872 dietary supplement Nutrition 0.000 title abstract 2
- 208000021302 gastroesophageal reflux disease Diseases 0.000 title abstract 2
- 208000024891 symptom Diseases 0.000 title 1
- 206010008479 Chest Pain Diseases 0.000 abstract 2
- 208000019505 Deglutition disease Diseases 0.000 abstract 1
- 206010013952 Dysphonia Diseases 0.000 abstract 1
- 208000010473 Hoarseness Diseases 0.000 abstract 1
- 206010030094 Odynophagia Diseases 0.000 abstract 1
- 206010067171 Regurgitation Diseases 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 238000010992 reflux Methods 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
Classifications
-
- H—ELECTRICITY
- H03—ELECTRONIC CIRCUITRY
- H03F—AMPLIFIERS
- H03F3/00—Amplifiers with only discharge tubes or only semiconductor devices as amplifying elements
- H03F3/45—Differential amplifiers
- H03F3/45071—Differential amplifiers with semiconductor devices only
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
SUPLEMENTAçãO DIETéTICA PARA CURAR OU REGREDIR SINTOMAS DE REFLUXO GASTROESOFáGICO, GASTRITES E úLCERAS A presente invenção apresenta um medicamento obtido a partir de uma mistura de vitaminas e aminoácidos, que permite a cura de quadros da doença do refluxo gastroenterológico, gastrites, úlceras e ulcerações de vários níveis, e dos conseqüentes problemas originários deste tipo de patologia, tais como, disfagia, dor e queimação no peito, regurgitação, rouquidão e odinofagia.
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0601834-3A BRPI0601834A (pt) | 2006-03-30 | 2006-03-30 | suplementação dietética para curar ou regredir sintomas de refluxo gastroesofágico, gastrite e úlceras |
CA002647484A CA2647484A1 (en) | 2006-03-30 | 2007-01-19 | Dietary supplement for healing or regressing symptoms of gastroesophageal reflux disease, gastritis and ulcers |
EP07701598A EP2004187A1 (en) | 2006-03-30 | 2007-01-19 | Dietary supplement for healing or regressing symptoms of gastroesophageal reflux disease, gastritis and ulcers |
PCT/BR2007/000012 WO2007112524A1 (en) | 2006-03-30 | 2007-01-19 | Dietary supplement for healing or regressing symptoms of gastroesophageal reflux disease, gastritis and ulcers |
US12/161,214 US20100221325A1 (en) | 2006-03-30 | 2007-01-19 | Dietary supplement for healing or regressing symptoms of gastroesophageal reflux disease, gastritis and ulcers |
US12/241,759 US20090022788A1 (en) | 2006-03-30 | 2008-09-30 | Dietary supplement for healing or regressing symptoms of gastroesophageal reflux disease, gastritis and ulcers |
US13/691,923 US20130090305A1 (en) | 2006-03-30 | 2012-12-03 | Method using a dietary supplement for healing or regressing symptoms of gastroesophageal reflux disease, gastritis and ulcers |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0601834-3A BRPI0601834A (pt) | 2006-03-30 | 2006-03-30 | suplementação dietética para curar ou regredir sintomas de refluxo gastroesofágico, gastrite e úlceras |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0601834A true BRPI0601834A (pt) | 2007-11-27 |
Family
ID=38563011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0601834-3A BRPI0601834A (pt) | 2006-03-30 | 2006-03-30 | suplementação dietética para curar ou regredir sintomas de refluxo gastroesofágico, gastrite e úlceras |
Country Status (5)
Country | Link |
---|---|
US (3) | US20100221325A1 (pt) |
EP (1) | EP2004187A1 (pt) |
BR (1) | BRPI0601834A (pt) |
CA (1) | CA2647484A1 (pt) |
WO (1) | WO2007112524A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3028709B1 (en) * | 2010-02-24 | 2019-08-28 | Emisphere Technologies, Inc | Oral b12 therapy |
WO2020011629A1 (en) | 2018-07-07 | 2020-01-16 | Ivica Cepanec | Composition of powderous instant drink, its preparation and use |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3988466A (en) * | 1973-06-01 | 1976-10-26 | Kyowa Hakko Kogyo Co., Ltd. | Prevention of gastric lesions |
US20050090553A1 (en) * | 1992-06-30 | 2005-04-28 | Shapiro Howard K. | Compositions and method for treatment of chronic inflammatory diseases |
US5703127A (en) * | 1996-01-25 | 1997-12-30 | Pak; Kyoungsik | Composition, dosage unit, and method for treating stomach disorders |
EP0951842B1 (en) * | 1999-01-20 | 2002-12-04 | N.V. Nutricia | Infant formula |
US20030194430A1 (en) * | 2002-04-10 | 2003-10-16 | Miller Frederick H. | Process for encapsulating multi-phase, multi-compartment capsules for therapeutic compositions |
US7105691B2 (en) * | 2003-06-26 | 2006-09-12 | Colgate-Palmolive Company | Aluminum / zirconium / glycine antiperspirant actives stabilized with Betaine |
CN100349578C (zh) * | 2005-04-29 | 2007-11-21 | 朱舜时 | 治疗萎缩性胃炎的药物组合物 |
US20070202058A1 (en) * | 2006-02-27 | 2007-08-30 | Calwood Nutritionals, Inc. | Compositions for treating gastric reflux |
-
2006
- 2006-03-30 BR BRPI0601834-3A patent/BRPI0601834A/pt not_active Application Discontinuation
-
2007
- 2007-01-19 US US12/161,214 patent/US20100221325A1/en not_active Abandoned
- 2007-01-19 WO PCT/BR2007/000012 patent/WO2007112524A1/en active Application Filing
- 2007-01-19 EP EP07701598A patent/EP2004187A1/en not_active Withdrawn
- 2007-01-19 CA CA002647484A patent/CA2647484A1/en not_active Abandoned
-
2008
- 2008-09-30 US US12/241,759 patent/US20090022788A1/en not_active Abandoned
-
2012
- 2012-12-03 US US13/691,923 patent/US20130090305A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20090022788A1 (en) | 2009-01-22 |
US20130090305A1 (en) | 2013-04-11 |
US20100221325A1 (en) | 2010-09-02 |
WO2007112524A1 (en) | 2007-10-11 |
EP2004187A1 (en) | 2008-12-24 |
CA2647484A1 (en) | 2007-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121492T1 (el) | Φαρμακευτικος συνδυασμος 3-(3-διμεθυλαμινο-1-αιθυλ-2-μεθυλ-προπυλ)-φαινολης και πρεγκαμπαλινης ή γκαμπαπεντινης | |
CY1121350T1 (el) | Απο του στοματος φαρμακοτεχνικες μορφες αναλογων κυτιδινης και μεθοδοι χρησης αυτων | |
BR112013021236A2 (pt) | composto, composição,e, método de tratamento de um distúrbio, uma condição ou uma doença | |
CO6270312A2 (es) | Moduladores de gpr40 bifenilo-sustituidos | |
UY30477A1 (es) | Derivados de [4,5']bipirimidinil-6,4´-diamina como inhibidores de cinasa de proteina | |
BR112012001297A2 (pt) | conector. | |
EA200901166A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr 119 | |
ECSP066734A (es) | Derivados de ácido 7-fenilamino-4-quinolona-3-carboxílico, métodos para su producción y su uso como medicamentos | |
BR112014007532A2 (pt) | variantes do fator de crescimento de fibroblastos 21 | |
EA200901032A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
EA201290209A1 (ru) | Новые модуляторы бензопиран киназы | |
EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
BRPI0818079A8 (pt) | Composição de lipídeo | |
BRPI0513858A (pt) | compostos de benziltriazolona como inibidores não-nucleosìdeos da transcriptase reversa | |
DOP2007000053A (es) | Compuestos de tetrahidropiridotienopirimidina y métodos para su empleo | |
BR112014007675A2 (pt) | tratamento de doença articular degenerativa | |
BRPI0605214A (pt) | composição farmacêutica orodispersável para administração por via mucosa oral ou sublingual de agomelatina | |
ECSP055985A (es) | Derivados de ácido 3-metil-2-(3-(2-fenil-oxazol-4-ilmetoxi)-ciclohexanocarbonil-aminobutírico y compuestos relacionados como moduladores de ppar para el tratamiento de diabetes de tipo 2 y aterosclerosis | |
BRPI0911031B8 (pt) | compostos de piperidina ligada do tipo quinoxalina substituídos e os usos destes | |
UY28976A1 (es) | Uso de benzopiranonas trisustituidas | |
BRPI0820668A2 (pt) | Derivados de oxindol substituídos por 5-halogênio e seu uso para tratar doenças dependentes de vasopressina | |
BRPI0905687A8 (pt) | composto da fórmula i ou i', composição farmacêutica, método de tratamento de um paciente com uma doença, uso do composto | |
ECSP099518A (es) | Uso de derivados de ácido de piranona sustituidos para el tratamiento del síndrome metabólico | |
TR201821157T4 (tr) | İbandroni̇k asi̇t veya bunun farmasöti̇k olarak kabul edi̇lebi̇li̇r bi̇r tuzu ve d vi̇tami̇ni̇ i̇çeren oral uygulamaya yöneli̇k kati bi̇leşi̇m. | |
BR112015011759A2 (pt) | composição simbiótica e uso da mesma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |